⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9341164 | 1.00 | — | — | |
| SCHEMBL9308623 | 1.00 | — | — | |
| SCHEMBL10638101 | 1.00 | — | — | |
| SCHEMBL8831528 | 1.00 | — | — | |
| SCHEMBL42377 | 1.00 | — | — | |
| SCHEMBL2256620 | 1.00 | — | — | |
| SCHEMBL217 | 1.00 | — | — | |
| SCHEMBL4958475 | 1.00 | — | — | |
| SCHEMBL7160419 | 1.00 | — | — | |
| SCHEMBL317639 | 1.00 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-111295451-A | Signal amplification in biosensor devices | 艾维亚纳分子技术有限公司 | 2020-06-16 | — | — | CN | disclosed |
| CN-110041253-A | Pyridines N- oxidized derivatives and its preparation method and application | 上海翰森生物医药科技有限公司 | 2019-07-23 | — | — | CN | disclosed |
| CN-109836385-A | Tetrahydro chinolines N- oxidized derivatives and its preparation method and application | 上海翰森生物医药科技有限公司 | 2019-06-04 | — | — | CN | disclosed |
| CN-101494999-A | Method for using organic compound | GIVAUDAN SA (CH) | 2009-07-29 | — | — | CN | disclosed |
| EP-1720862-A1 | KINASE INHIBITORS | ELI LILLY AND COMPANY (US) | 2006-11-15 | — | — | EP | disclosed |
| WO-2005080380-A1 | KINASE INHIBITORS | ELI LILLY AND COMPANY (US) | 2005-09-01 | — | — | WO | disclosed |
| WO-2004052363-A1 | OXAZOLIDINONES USED AS ANTIVIRAL AGENTS, IN PARTICULAR FOR FIGHTING AGAINST CYTOMEGALOVIRUS | BAYER HEALTHCARE AG (DE) | 2004-06-24 | — | — | WO | disclosed |
| US-6727229-B2 | MACROLIDE ANTIBIOTICS PLAY A THERAPEUTICALLY IMPORTANT ROLE, PARTICULARLY WITH THE EMERGENCE OF NEW PATHOGENS | ENANTA PHARMACEUTICALS, INC. | 2004-04-27 | — | — | US | disclosed |
| US-5962372-A | INSECTICIDES, HERBICIDES | BAYER AKTIENGESELLSCHAFT (DE) | 1999-10-05 | — | — | US | disclosed |
| EP-0920441-A1 | 7ALPHA-(EPSILON-AMINOALKYL)-ESTRATRIENES, PROCESS FOR PREPARING THE SAME, PHARMACEUTICAL PREPARATIONS CONTAINING SAID 7ALPHA-(EPSILON-AMINOALKYL)-ESTRATRIENES AND THEIR USE FOR PREPARING MEDICAMENT | SCHERING AKTIENGESELLSCHAFT (DE) | 1999-06-09 | — | — | EP | disclosed |
| WO-1998007740-A1 | 7α-(κ-AMINOALKYL)ESTRATRIENES, PROCESS FOR PREPARING THE SAME, PHARMACEUTICAL PREPARATIONS CONTAINING SAID 7α-(κ-AMINOALKYL)ESTRATRIENES AND THEIR USE FOR PREPARING MEDICAMENTS | SCHERING AKTIENGESELLSCHAFT (DE) | 1998-02-26 | — | — | WO | disclosed |